Monoclonal antibody NM01

Drug Profile

Monoclonal antibody NM01

Alternative Names: hNM01

Latest Information Update: 12 Sep 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SRD Pharmaceuticals
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 13 May 2004 SRD Pharmaceuticals has acquired all patents related to hNM01
  • 02 Sep 2002 Preclinical trials in HIV infections treatment in Canada (unspecified route)
  • 15 Aug 2002 Immune Network and AbNovo will collaborate in the development of antibody-based therapeutics for viral diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top